Pierce Universal Nuclease for Cell Lysis, 100 kU and 2 more items

Life Technologies Corporation was awarded contract A207_PO-0481058-V3 by the University of Virginia on October 10, 2026, with a cumulative contract value of $1,509.01. The contract is classified as a purchase order within Virginia. Life Technologies Corporation serves as the prime contractor responsible for fulfilling all deliverables under this award.

The contract encompasses the delivery of three distinct laboratory reagent products, all supplied by Life Technologies Corporation's Pierce product line. The line items include 1,200 units of Pierce Universal Nuclease for Cell Lysis (100 kiloUnits), 129 units of Pierce Trifluoroacetic Acid in sequencing grade (10 x 1 milliliter format), and 179 units of Pierce Bovine Serum Albumin Standard Ampules (2 milligrams per milliliter concentration). All materials are to be delivered to the buyer at the University of Virginia. These reagents are consumable supplies utilized in molecular biology and protein analysis applications within research laboratory environments.